Buffalo General Celebrates 200th COVID-19 Patient Discharged & She was one of their own staff members

May 21, 2020

Written By

Mary Friona Celani

Andrea Holloway, a 28-year-old patient care assistant at Buffalo General Medical Center, today was discharged after a nearly month-long battle with COVID-19. She was Kaleida Health’s first recipient of the antiviral drug, Remdesivir, as part of a clinical trial.

Andrea’s coworkers today held a farewell celebration as she departed the hospital and was reunited with her father and daughter. Not only was she finally able to return home, but Andrea was also the 200th patient discharged from Buffalo General Medical Center after recovering from COVID-19.

“Andrea is a fighter. She really fought hard, and we are all so proud of her,” said Dr. Jamie Nadler, critical care physician at Buffalo General Medical Center, who oversaw her treatment.

Andrea noted, “Every step of the way, I received only the best care from the most compassionate people. All of the nurses were so great, kept my family updated, and showed me how to use the iPad to keep me connected with my family. That meant so much to me. It made me feel less alone in this battle.”

“Each patient that recovers from COVID-19 and is released from the hospital is cause for celebration,” said Chris Lane, president, Buffalo General Medical Center/Gates Vascular Institute. “Our staff has done incredible work in caring for these often very sick patients and getting them back to the point of being able to return home to their loved ones. It was especially heartening to see one of our own get back to her home and family.”



About Me

Welcome to Totally Buffalo! My name is Mary Friona-Celani and I am the creator of this site! After spending 20 years in the Buffalo media, I moved on to focus on my beautiful family. Now, the time has come for a new project. I was ready for something new. Something mine.
I am born and raised in WNY and my pride runs deep. My husband, Scott and I are very happy to be raising our four daughters here.






Submit a Comment